Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 35.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 78.50
  • 52 Week Low: 31.50
  • Currency: UK Pounds
  • Shares Issued: 43.87m
  • Volume: 33,366
  • Market Cap: 15.57m
  • RiskGrade: 281

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 2.0  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Destiny Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 n/a (1.45) (4.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (3.21) (8.40)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (6.01) (11.90)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (5.52) (10.70)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Destiny Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (5.27) (9.10)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (5.14) (9.80)p n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Destiny Pharma Company Announcements

Posting of Annual Report and Notice of AGM 12-May-2020 15:15 RNS
Independent review supports the potential of XF-73 04-May-2020 07:00 RNS
Final Results 29-Apr-2020 07:00 RNS

Latest Destiny Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 35.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 78.50
52 Week Low 31.50
Volume 33,366
Shares Issued 43.87m
Market Cap 15.57m
RiskGrade 281

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.17% below the market average17.17% below the market average17.17% below the market average17.17% below the market average17.17% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Price Trend
63.04% below the market average63.04% below the market average63.04% below the market average63.04% below the market average63.04% below the market average
78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average
Income Not Available
Growth Not Available

Destiny Pharma Dividends

No dividends found

Trades for 03-Jun-2020

Time Volume / Share Price
16:23 83 @ 35.90p
16:11 15,000 @ 35.85p
15:18 330 @ 35.10p
14:50 2,000 @ 35.85p
14:00 2,000 @ 36.00p

Destiny Pharma Key Personnel

CEO Neil Clark
Chair Nick Rodgers

Top of Page